EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects

Hao Chen, Abhi Shah, Suguru Kato, Robert Griffin, Steven Zhang, Sandeepraj Pusalkar iD, Lawrence Cohen, Yuexian Li, Swapan K Chowdhury, Sean Xiaochun Zhu iD

Drug Metabolism and Disposition · 2024

DOI: 10.1124/dmd.124.001841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Hao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S…. Hauptthemen laut MEDLINE: ErbB Receptors, Protein Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsProtein Kinase InhibitorsHumansMaleAdultHealthy VolunteersExonsAdministration, OralCarbon RadioisotopesMutagenesis, InsertionalYoung AdultFecesMiddle AgedAniline CompoundsIndolesPyrimidines

Substanzen

ErbB ReceptorsEGFR protein, humanProtein Kinase InhibitorsmobocertinibCarbon RadioisotopesCarbon-14Aniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Develop…

ORCID-Profile: Sandeepraj Pusalkar, Sean Xiaochun Zhu

Zitieren

APA

Chen, H., Shah, A., Kato, S., Griffin, R., Zhang, S., Pusalkar, S., Cohen, L., Li, Y., Chowdhury, S. K., & Zhu, S. X. (2024). Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001841

Vancouver

Chen H, Shah A, Kato S, Griffin R, Zhang S, Pusalkar S, et al. Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001841

BibTeX
@article{Chen2024,
  author = {Chen, Hao and Shah, Abhi and Kato, Suguru and Griffin, Robert and Zhang, Steven and Pusalkar, Sandeepraj and Cohen, Lawrence and Li, Yuexian and Chowdhury, Swapan K and Zhu, Sean Xiaochun},
  title = {Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  doi = {10.1124/dmd.124.001841}
}
Kostenlos starten →